Targeted proteomics: A bridge between discovery and validation

Robert Harlan, Hui Zhang

Research output: Contribution to journalArticle

Abstract

New technologies in mass spectrometry are beginning to mature and show unique advantages for the identification and quantitation of proteins. In recent years, one of the significant goals of clinical proteomics has been to identify biomarkers that can be used for clinical diagnosis. As technology has progressed, the list of potential biomarkers has grown. However, the verification and validation of these potential biomarkers is increasingly challenging and require high-throughput quantitative assays, targeting specific candidates. Targeted proteomics bridges the gap between biomarker discovery and the development of clinically applicable biomarker assays.

Original languageEnglish (US)
Pages (from-to)657-661
Number of pages5
JournalExpert Review of Proteomics
Volume11
Issue number6
DOIs
StatePublished - Dec 1 2014

Keywords

  • LCMS
  • MRM, PRM
  • SRM
  • biomarker
  • proteomics
  • targeted proteomics

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology

Fingerprint Dive into the research topics of 'Targeted proteomics: A bridge between discovery and validation'. Together they form a unique fingerprint.

  • Cite this